Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol for skeletal muscle glucose uptake in obese adults
NL-OMON51975Phase 2Completed
- Sponsor
- Maastricht University
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in insulin resistance (IR) and obesity comparing Clenbuterol with Placebo (2 arms). Primary endpoint: Insulin-stimulated quadriceps muscle 18F-FDG uptake. Started Aug 2022; status: completed.
02
Drugs
clenbuterol
03
Conditions
insulin resistance (IR)obesity
Beyond the preview
Go deeper on NL-OMON51975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51975.